Endoscopic full-thickness plication along with argon plasma coagulation for treatment of proton pump inhibitor dependent gastroesophageal reflux disease

被引:0
|
作者
Harwani, Yogesh [1 ]
Butala, Shreya [2 ]
More, Balaji [3 ,5 ]
Shukla, Varun [4 ]
Patel, Anand [4 ]
机构
[1] Nobel Gastro Hosp, Dept Gastroenterol, Ahmadabad 408409, Gujarat, India
[2] Sanjay Gandhi Post Grad Inst Med Sci, Dept Gastroenterol, Lucknow 226014, Uttar Pradesh, India
[3] Mahatma Gandhi Med Coll & Res Inst, Dept Pharmacol, Pondicherry 607402, India
[4] Noble Inst Gastroenterol, Dept Gastroenterol, Ahmadabad 380009, Gujrat, India
[5] Mahatma Gandhi Med Coll & Res Inst, Dept Pharmacol, Sri Balaji Vidyapeeth, Pondicherry Cuddalore Rd,ECR, Pondicherry 607402, India
来源
WORLD JOURNAL OF GASTROINTESTINAL ENDOSCOPY | 2024年 / 16卷 / 05期
关键词
Gastroesophageal reflux disease; Endoscopy; Quality of life; Endoscopic antireflux interventions; Retrospective data analysis; Gastroesophageal reflux disease symptom scores; Proton pump inhibitor; TRANSORAL INCISIONLESS FUNDOPLICATION; QUALITY-OF-LIFE; CHRONIC GERD; LAPAROSCOPIC FUNDOPLICATION; ANTIREFLUX MUCOSECTOMY; MULTICENTER; TRIAL; EFFICACY; OUTCOMES;
D O I
10.4253/wjge.v16.i5.250
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND Most endoscopic anti-reflux interventions for gastroesophageal reflux disease (GERD) management are technically challenging to practice with inadequate data to support it utility. Therefore, this study was carried to evaluate the effectiveness and safety newer endoscopic full-thickness fundoplication (EFTP) device along with Argon Plasma Coagulation to treat individuals with GERD. AIM To evaluate the effectiveness and safety newer EFTP device along with Argon Plasma Coagulation to treat individuals with GERD. METHODS This study was a single-center comparative analysis conducted on patients treated at a Noble Institute of Gastroenterology, Ahmedabad, hospital between 2020 and 2022. The research aimed to retrospectively analyze patient data on GERD symptoms and proton pump inhibitor (PPI) dependence who underwent EFTP using the GERD-X system along with argon plasma coagulation (APC). The primary endpoint was the mean change in the total gastroesophageal reflux disease health-related quality of life (GERD-HRQL) score compared to the baseline measurement at the 3-month follow-up. Secondary endpoints encompassed enhancements in the overall GERD-HRQL score, improvements in GERD symptom scores at the 3 and changes in PPI usage at the 3 and 12-month time points. RESULTS In this study, patients most were in Hill Class II, and over half had ineffective esophageal motility. Following the EFTP procedure, there were significant improvements in heartburn and regurgitation scores, as well as GERD-HRQL scores (P < 0.001). PPI use significantly decreased, with 82.6% not needing PPIs or prokinetics at end of 1 year. No significant adverse events related to the procedures were observed in either group. CONCLUSION The EFTP along with APC procedure shows promise in addressing GERD symptoms and improving patients' quality of life, particularly for suitable candidates. Moreover, the application of a lone clip with APC yielded superior outcomes and exhibited greater cost-effectiveness.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] The proton pump inhibitor test and the diagnosis of gastroesophageal reflux disease
    Pace, Fabio
    Pace, Marina
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 4 (04) : 423 - 427
  • [22] FACTORS AFFECTING EFFICACY OF GASTROESOPHAGEAL REFLUX DISEASE TREATMENT WITH PROTON PUMP INHIBITORS
    Lazebnik, L. B.
    Bordin, D. S.
    Masharova, A. A.
    Firsova, L. D.
    Silvestrova, S. Yu.
    TERAPEVTICHESKII ARKHIV, 2012, 84 (02) : 16 - 21
  • [23] Prevalence of Gastroesophageal Reflux Disease and Proton Pump Inhibitor-Refractory Symptoms
    Delshad, Sean D.
    Almario, Christopher V.
    Chey, William D.
    Spiegel, Brennan M. R.
    GASTROENTEROLOGY, 2020, 158 (05) : 1250 - +
  • [24] Comparing the efficacy of different proton pump inhibitor dosing regimens for the treatment of gastroesophageal reflux disease: a systematic review and meta-analysis
    Nguyen, Tyra
    Barnhill, Katherine
    Zhornitskiy, Alex
    Yu, Kyung Sang
    Fuller, Garth
    Makaroff, Katherine
    Spiegel, Brennan M. R.
    Gresham, Gillian
    Almario, Christopher, V
    DISEASES OF THE ESOPHAGUS, 2024, 38 (01)
  • [25] Symptom Predictability in Gastroesophageal Reflux Disease and Role of Proton Pump Inhibitor Test
    Estores, David S.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2014, 43 (01) : 27 - +
  • [26] How safe and effective is endoscopic full-thickness plication for the treatment of patients with GERD?
    Hongo, M
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2005, 2 (11): : 514 - 515
  • [27] Comparison of Gastroesophageal Reflux Disease Symptoms and Proton Pump Inhibitor Response Using Gastroesophageal Reflux Disease Impact Scale Questionnaire
    Jo, So Young
    Kim, Nayoung
    Lim, Ji Hwan
    Shin, Cheol Min
    Park, Young Soo
    Lee, Dong Ho
    Jung, Hyun Chae
    JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2013, 19 (01) : 61 - 69
  • [28] Full-thickness myotomy is associated with higher rate of postoperative gastroesophageal reflux disease
    Xue-Hong Wang
    Yu-Yong Tan
    Hong-Yi Zhu
    Chen-Jie Li
    De-Liang Liu
    World Journal of Gastroenterology, 2016, (42) : 9419 - 9426
  • [29] Factors affecting response to proton pump inhibitor therapy in patients with gastroesophageal reflux disease: a multicenter prospective observational study
    Matsuhashi, Nobuyuki
    Kudo, Mineo
    Yoshida, Norimasa
    Murakami, Kazunari
    Kato, Mototsugu
    Sanuki, Tsuyoshi
    Oshio, Atsushi
    Joh, Takashi
    Higuchi, Kazuhide
    Haruma, Ken
    Nakada, Koji
    JOURNAL OF GASTROENTEROLOGY, 2015, 50 (12) : 1173 - 1183
  • [30] Overview of pediatric gastroesophageal reflux disease and proton pump inhibitor therapy
    Colletti, RB
    Di Lorenzo, C
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2003, 37 : S7 - S11